
As Congress prepares to adjourn, tech companies and regulation advocates are making themselves heard.
The advocates are pushing for some major bills in Congress. At the same time, the tech companies have deployed over $100 million in lobbying efforts, advertising programs and grassroots pressure to oppose them, the Wall Street Journal reported Monday (Dec. 19).
Among the bills currently active in Congress are ones covering online privacy protection, legal liability for content on social media platforms and antitrust rules, according to the report.
The Biden administration joined those advocating for bills that would add protections for children online and would limit the ability of Apple and Google to control the apps meant for their devices, the report said.
Read more: Congressional Recess Delays Big Tech Vote To November
Tech company lobbyists, on the other hand, have said that most Americans don’t see a need for regulation and that the bills threaten national security, user privacy and content moderation, per the report.
There’s expected to be less chance for bills to pass after the new Congress convenes in January because that Congress will be politically divided, according to the report. At that point, any regulation is more likely to come from federal regulators and the courts.
Already, the Supreme Court has agreed to hear a case against Google that contends that courts have too broadly interpreted a federal shield law and the Federal Trade Commission (FTC) is considering privacy protections around children and targeted advertising. In addition, the Labor Department and National Labor Relations Board (NLRB) are looking at rules defining the status of gig workers and the Biden Administration is weighing rules to protect American consumers’ privacy from foreign-owned apps like TikTok, per the report.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas